Protective antitumor immunity induced by tumor cell lysates conjugated with diphtheria toxin and adjuvant epitope in mouse breast tumor models
Zeyu Wang(Anhui University), Jingjing Liu(Tianjin Medical University Cancer Institute and Hospital), Wenjun Yao(China Pharmaceutical University), Maolei Xu(State Key Laboratory of Natural Medicine), Bin Liu(Shaanxi Science and Technology Department), Xiao Huang(State Key Laboratory of Natural Medicine), Lei Lü(State Key Laboratory of Natural Medicine), Rongyue Cao(China Pharmaceutical University), Jie Wu(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhenqiu Gao(State Key Laboratory of Natural Medicine), Taiming Li(China Pharmaceutical University), Chiyu Ge(State Key Laboratory of Natural Medicine), Yun Xing(Fudan University)
Cited by 8
Related Papers
Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
|Journal of Experimental & Clinical Cancer Research|2021|535
Splicing factor derived circular RNA circUHRF1 accelerates oral squamous cell carcinoma tumorigenesis via feedback loop
|Cell Death and Differentiation|2019|307
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
|Journal of Hematology & Oncology|2022|273
Epigenetic Regulation of m6A Modifications in Human Cancer
|Molecular Therapy — Nucleic Acids|2019|271